{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:31:27Z","timestamp":1772224287423,"version":"3.50.1"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamadermatol.2020.4937","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T16:34:27Z","timestamp":1608741267000},"page":"238","source":"Crossref","is-referenced-by-count":9,"title":["Emerging Evidence of the Direct Association Between COVID-19 and Chilblains"],"prefix":"10.1001","volume":"157","author":[{"given":"Esther E.","family":"Freeman","sequence":"first","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devon E.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy P.","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"9","key":"dle200010r1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of chilblains as a manifestation of the COVID-19 pandemic.","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"22","key":"dle200010r2","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2.","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"dle200010r3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries.","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"dle200010r4","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30518-1","article-title":"Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.","author":"Hubiche","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"dle200010r5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.v183.4","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2774509\/jamadermatology_freeman_2020_le_200010_1612543409.51031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T18:37:30Z","timestamp":1613587050000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2774509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.4937","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}